ophthalmology
Roche set to file ophthalmology drug faricimab in DME
Richard Staines
faricimab, Novartis, ophthalmology, Roche
0 Comment
Novartis signs ophthalmology AI deal with RetinAI
Richard Staines
digital, Novartis, ophthalmology, RetinAI Medical
0 Comment
Janssen adds Hemera’s AMD gene therapy to pipeline
Richard Staines
Hemera, Janssen, Johnson & Johnson, M&A, ophthalmology, R&D
0 Comment
Novartis taps smartpatient for app to support wet AMD patients
Phil Taylor
app, Beovu, digital, digital health, Lucentis, Novartis, ophthalmology, smartpatient, wet AMD
0 Comment
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Richard Staines
Biogen, biosimilars, market access, Novartis, ophthalmology, Samsung Bioepis
0 Comment
News/ News/ R&D/ Top stories
Novartis keeps a close eye on gene therapy with Vedere Bio buy
Phil Taylor
gene therapy, M&A, Novartis, ophthalmology, Vedere Bio
0 Comment
SparingVision raises €44.5m for retinitis pigmentosa gene therapy
Richard Staines
Funding, ophthalmology, Oxford Biomedica, R&D, Sanofi, SparingVision
0 Comment
Takeda to make $200m loss after Novartis’ dry-eye drug hits trouble in Europe
Richard Staines
Novartis, ophthalmology, regulation, Shire, Takeda, Xiidra
0 Comment